1st Quarter - Report

CHILDREN'S HEALTHCARE OF ATLANTA for CHILDREN'S HEALTHCARE OF ATLANTA

Firm
Client
Income
—
Expenses
$110,597
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of health care reform generally pertaining to pediatric health care and autism services Medicaid program reforms, including telemedicine and Medicaid Fiscal Accountability Regulation Section 340B Drug Pricing Program Sickle Cell Disease research funding generally Drug pricing reforms generally Organ transplant policy generally, including liver transplant distribution methodology Implementation of Children's Hospital Graduate Medical Education program Mental and behavioral health legislation generally CMS policies related to COVID-19 patients

LobbyistCovered position, as disclosed
JAMILA POPE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Autism research programs and autism intervention programs generally, including Department of Justice program on elopement Department of Defense programs regarding autism research Department of Health and Human Services programs regarding autism and sickle cell disease research Fiscal Year 2022 Department of Health and Human Services appropriations regarding National Institutes of Health funding, Children's Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care H.R. 1319 (American Rescue Plan Act of 2021), Titles II and IX, regarding Health and Human Services funding H.R. 1848 (LIFT America Act), Title IV, regarding hospital funding

LobbyistCovered position, as disclosed
JAMILA POPE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1848 (117th), H.R. 1319 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.